ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "MDT perspectives on unlocking the data on PARPi to support shared decision-making in mCRPC - Video 1"
Episode Synopsis
touchMDT for touchONCOLOGY
MDT perspectives on unlocking the data on PARPi to support shared decision-making in mCRPC
Experts Dr Alicia Morgans and Dr Grace Cullen share insights into using evidence to guide practice and shared decision-making with patients with metastatic castration-resistant prostate cancer (mCRPC).
The multidisciplinary team:
Medical oncologist – Dr Alicia Morgans
Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Nurse practitioner – Dr Grace Cullen
John D. Dingell VA Medical Center, Detroit, Michigan, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is supported by an independent medical education funding request from AstraZeneca.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: https://touchoncologyime.org/mdt-parp-inhibitors-in-mcrpc/
MDT perspectives on unlocking the data on PARPi to support shared decision-making in mCRPC
Experts Dr Alicia Morgans and Dr Grace Cullen share insights into using evidence to guide practice and shared decision-making with patients with metastatic castration-resistant prostate cancer (mCRPC).
The multidisciplinary team:
Medical oncologist – Dr Alicia Morgans
Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Nurse practitioner – Dr Grace Cullen
John D. Dingell VA Medical Center, Detroit, Michigan, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is supported by an independent medical education funding request from AstraZeneca.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: https://touchoncologyime.org/mdt-parp-inhibitors-in-mcrpc/
In God we trust